EcoR1 Capital as of Sept. 30, 2020
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 47 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Xencor (XNCR) | 12.6 | $176M | 4.5M | 38.79 | |
| Kura Oncology (KURA) | 10.1 | $141M | 4.6M | 30.64 | |
| Relay Therapeutics (RLAY) | 9.7 | $136M | 3.2M | 42.59 | |
| Prothena Corp SHS (PRTA) | 6.7 | $94M | 9.4M | 9.99 | |
| Morphic Hldg (MORF) | 5.5 | $78M | 2.8M | 27.34 | |
| Mirati Therapeutics | 5.5 | $77M | 464k | 166.05 | |
| Oric Pharmaceuticals (ORIC) | 4.7 | $66M | 2.6M | 25.01 | |
| Avidity Biosciences Ord (RNA) | 4.2 | $59M | 2.1M | 28.15 | |
| Anaptysbio Inc Common (ANAB) | 3.4 | $48M | 3.2M | 14.75 | |
| Neoleukin Therapeutics | 3.3 | $46M | 3.9M | 12.00 | |
| Akouos | 3.2 | $45M | 2.0M | 22.87 | |
| Assembly Biosciences Call Option | 3.0 | $42M | 2.6M | 16.46 | |
| Nurix Therapeutics (NRIX) | 3.0 | $42M | 1.2M | 34.91 | |
| Applied Molecular Trans | 2.6 | $37M | 1.2M | 31.82 | |
| Atreca Cl A Com (BCEL) | 2.4 | $34M | 2.4M | 13.97 | |
| Geron Corporation (GERN) | 2.4 | $34M | 19M | 1.74 | |
| Sutro Biopharma (STRO) | 2.2 | $31M | 3.1M | 10.05 | |
| Arcus Biosciences Incorporated (RCUS) | 2.2 | $31M | 1.8M | 17.14 | |
| Gossamer Bio Note | 2.2 | $31M | 30M | 1.03 | |
| Surface Oncology | 1.6 | $23M | 3.3M | 6.90 | |
| Cyclerion Therapeutics | 1.2 | $17M | 2.7M | 6.08 | |
| Glycomimetics Call Option | 1.0 | $14M | 4.6M | 3.07 | |
| Allovir (ALVR) | 0.9 | $12M | 447k | 27.50 | |
| Bctg Acquisition Corp | 0.6 | $8.3M | 800k | 10.36 | |
| Constellation Pharmceticls I Call Option | 0.6 | $8.1M | 400k | 20.26 | |
| Lifesci Acquisition Corp | 0.6 | $7.8M | 631k | 12.40 | |
| Alpine Immune Sciences | 0.5 | $6.5M | 741k | 8.79 | |
| Iteos Therapeutics | 0.5 | $6.4M | 260k | 24.67 | |
| Deerfield Healthcare Tech Ac Unit 07/16/2025 | 0.4 | $5.3M | 500k | 10.63 | |
| Panacea Acquisition Corp Unit 99/99/9999 | 0.3 | $4.7M | 390k | 12.00 | |
| Ironwood Pharmaceuticals Com Cl A Call Option (IRWD) | 0.3 | $4.5M | 500k | 9.00 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.3 | $4.4M | 400k | 11.00 | |
| Dyne Therapeutics (DYN) | 0.3 | $4.3M | 215k | 20.19 | |
| Aclaris Therapeutics (ACRS) | 0.3 | $3.9M | 1.5M | 2.57 | |
| Fs Dev Corp Com Cl A | 0.3 | $3.9M | 350k | 11.20 | |
| Metacrine Ord | 0.2 | $3.4M | 333k | 10.21 | |
| Kymera Therapeutics (KYMR) | 0.2 | $3.2M | 100k | 32.31 | |
| Royalty Pharma Shs Cl A (RPRX) | 0.2 | $2.1M | 50k | 42.08 | |
| Five Prime Therapeutics | 0.1 | $1.8M | 380k | 4.70 | |
| Exicure | 0.1 | $1.8M | 1.0M | 1.75 | |
| Pmv Pharmaceuticals (PMVP) | 0.1 | $1.8M | 50k | 35.50 | |
| Repare Therapeutics Ord (RPTX) | 0.1 | $1.5M | 50k | 30.78 | |
| Meiragtx Holdings (MGTX) | 0.1 | $1.3M | 95k | 13.24 | |
| Intercept Pharmaceuticals In Call Option | 0.1 | $1.0M | 25k | 41.46 | |
| Unity Biotechnology | 0.1 | $1.0M | 296k | 3.46 | |
| Xoma Corp Del Com New (XOMA) | 0.1 | $957k | 51k | 18.84 | |
| Savara (SVRA) | 0.0 | $62k | 57k | 1.10 |
